Enveric Biosciences, Inc. (ENVB) Operating income 2016–2025
Enveric Biosciences, Inc. (ENVB) annual operating income history from SEC filings — each fiscal year as reported.
-$8.8MFY2025 · since FY2016: -$5.4M → -$8.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.8M | +8.9% |
| FY2024 | -$9.6M | +41.4% |
| FY2023 | -$16.4M | +40.0% |
| FY2022 | -$27.4M | +57.6% |
| FY2021 | -$64.6M | -1050.4% |
| FY2020 | -$5.6M | -144.6% |
| FY2019 | -$2.3M | +67.9% |
| FY2018 | -$7.1M | +34.4% |
| FY2017 | -$10.9M | -102.5% |
| FY2016 | -$5.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice